- Home
- IMXI vs ORIC Comparison
IMXI vs ORIC Comparison
Compare IMXI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- ORIC
- Stock Information
- Founded
- IMXI 1994
- ORIC 2014
- Country
- IMXI United States
- ORIC United States
- Employees
- IMXI N/A
- ORIC N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- IMXI Technology
- ORIC Health Care
- Exchange
- IMXI Nasdaq
- ORIC Nasdaq
- Market Cap
- IMXI 278.2M
- ORIC 974.1M
- IPO Year
- IMXI N/A
- ORIC 2020
- Fundamental
- Price
- IMXI $14.48
- ORIC $10.52
- Analyst Decision
- IMXI Buy
- ORIC Strong Buy
- Analyst Count
- IMXI 6
- ORIC 10
- Target Price
- IMXI $19.60
- ORIC $17.33
- AVG Volume (30 Days)
- IMXI 435.1K
- ORIC 903.1K
- Earning Date
- IMXI 11-07-2025
- ORIC 11-11-2025
- Dividend Yield
- IMXI N/A
- ORIC N/A
- EPS Growth
- IMXI N/A
- ORIC N/A
- EPS
- IMXI 1.65
- ORIC N/A
- Revenue
- IMXI $642,149,000.00
- ORIC N/A
- Revenue This Year
- IMXI N/A
- ORIC N/A
- Revenue Next Year
- IMXI $1.87
- ORIC N/A
- P/E Ratio
- IMXI $8.81
- ORIC N/A
- Revenue Growth
- IMXI N/A
- ORIC N/A
- 52 Week Low
- IMXI $8.58
- ORIC $3.90
- 52 Week High
- IMXI $22.37
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- IMXI 69.47
- ORIC 51.83
- Support Level
- IMXI $14.45
- ORIC $10.37
- Resistance Level
- IMXI $14.57
- ORIC $11.16
- Average True Range (ATR)
- IMXI 0.12
- ORIC 0.53
- MACD
- IMXI -0.17
- ORIC 0.03
- Stochastic Oscillator
- IMXI 26.98
- ORIC 46.43
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.